Surrogate endpoints in clinical trials of chronic kidney disease progression: moving from single to multiple risk marker response scores.
about
Surrogate endpoints in clinical trials of chronic kidney disease progression: moving from single to multiple risk marker response scores.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Surrogate endpoints in clinica ...... e risk marker response scores.
@en
type
label
Surrogate endpoints in clinica ...... e risk marker response scores.
@en
prefLabel
Surrogate endpoints in clinica ...... e risk marker response scores.
@en
P1476
Surrogate endpoints in clinica ...... e risk marker response scores.
@en
P2093
Bauke Schievink
Hiddo J Lambers Heerspink
P304
P356
10.1097/MNH.0000000000000159
P50
P577
2015-09-01T00:00:00Z